These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15032699)

  • 21. Alkaloid delta agonist BW373U86 increases hypoxic tolerance.
    Bofetiado DM; Mayfield KP; D'Alecy LG
    Anesth Analg; 1996 Jun; 82(6):1237-41. PubMed ID: 8638797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased tumor necrosis factor-alpha and nitric oxide production by rat macrophages following in vitro stimulation and intravenous administration of the delta-opioid agonist SNC 80.
    Gomez-Flores R; Rice KC; Zhang X; Weber RJ
    Life Sci; 2001 May; 68(24):2675-84. PubMed ID: 11400911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
    Patel HH; Hsu AK; Gross GJ
    Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral effects of delta-opioid receptor agonists: potential antidepressants?
    Broom DC; Jutkiewicz EM; Rice KC; Traynor JR; Woods JH
    Jpn J Pharmacol; 2002 Sep; 90(1):1-6. PubMed ID: 12396021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.
    Thomas JB; Herault XM; Rothman RB; Atkinson RN; Burgess JP; Mascarella SW; Dersch CM; Xu H; Flippen-Anderson JL; George CF; Carroll FI
    J Med Chem; 2001 Mar; 44(6):972-87. PubMed ID: 11300879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modeling directed synthesis of a bicyclic analogue of the delta opioid receptor agonist SNC 80.
    Jung B; Englberger W; Wünsch B
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):281-90. PubMed ID: 15938001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.
    Jutkiewicz EM; Walker NP; Folk JE; Rice KC; Portoghese PS; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1314-20. PubMed ID: 15574687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.
    Negus SS; Morgan D; Cook CD; Picker MJ
    Psychopharmacology (Berl); 1996 Aug; 126(3):199-205. PubMed ID: 8876019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept.
    Dondio G; Ronzoni S; Eggleston DS; Artico M; Petrillo P; Petrone G; Visentin L; Farina C; Vecchietti V; Clarke GD
    J Med Chem; 1997 Sep; 40(20):3192-8. PubMed ID: 9379438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The LMC delta opioid recognition pharmacophore: comparison of SNC80 and oxymorphindole.
    Coop A; Jacobson AE
    Bioorg Med Chem Lett; 1999 Feb; 9(3):357-62. PubMed ID: 10091684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A continuous flow process using a sequence of microreactors with in-line IR analysis for the preparation of N,N-diethyl-4-(3-fluorophenylpiperidin-4-ylidenemethyl)benzamide as a potent and highly selective δ-opioid receptor agonist.
    Qian Z; Baxendale IR; Ley SV
    Chemistry; 2010 Nov; 16(41):12342-8. PubMed ID: 20859972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms.
    Tierno A; Fiore P; Gannon RL
    Brain Res; 2002 May; 937(1-2):66-73. PubMed ID: 12020864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers.
    Furness MS; Zhang X; Coop A; Jacobson AE; Rothman RB; Dersch CM; Xu H; Porreca F; Rice KC
    J Med Chem; 2000 Aug; 43(16):3193-6. PubMed ID: 10956228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiparkinson potential of delta-opioid receptor agonists.
    Hudzik TJ; Howell A; Payza K; Cross AJ
    Eur J Pharmacol; 2000 May; 396(2-3):101-7. PubMed ID: 10822062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone Deacetylases Regulation by δ-Opioids in Human Optic Nerve Head Astrocytes.
    Zaidi SAH; Thakore N; Singh S; Guzman W; Mehrotra S; Gangaraju V; Husain S
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):17. PubMed ID: 32915982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
    Pakarinen ED; Woods JH; Moerschbaecher JM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):552-9. PubMed ID: 7853168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular mechanisms of cellular tolerance to delta-opioid agonists. A minireview.
    Varga EV
    Acta Biol Hung; 2003; 54(2):203-18. PubMed ID: 14535626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1998 Jan; 342(2-3):247-51. PubMed ID: 9548393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.